Hang Hu | Cancer Photodynamic Therapy | Best Researcher Award

Posted on by Best Paper Award

Dr. Hang Hu, Cancer Photodynamic Therapy, Best Researcher Award

Doctorate at Changzhou University, China

Summary:

Dr. Hang Hu is a dedicated researcher with expertise in cancer photodynamic therapy (PDT) and drug delivery systems. He completed his Bachelor’s degree in Applied Chemistry from Hubei University and pursued both a Master’s and a Doctorā€™s degree in Organic Chemistry and Biopharmaceutical Engineering at Huazhong University of Science and Technology. Dr. Hu’s research focuses on developing innovative strategies to enhance the efficacy of PDT by addressing challenges such as tumor hypoxia and insufficient photosensitizer uptake. Throughout his career, he has co-authored numerous SCI papers and holds multiple invention patents in the field. Dr. Hu’s work has been recognized for its originality and significance by prestigious journals in the field of materials science and healthcare.

Professional Profile:

Scopus Profile

šŸ‘©ā€šŸŽ“Education & Qualification:

Professional experience: Ā 

Dr. Hang Hu has extensive professional experience in the field of cancer photodynamic therapy and drug delivery systems. During graduate studies, Dr. Hu worked on constructing anticancer drug delivery systems using hydroylethyl starch-based materials and subsequently developed nanomedicines for cancer photodynamic therapy. Following the completion of a Doctoral degree, Dr. Hu served as a teacher at the School of Pharmacy, Changzhou University. Throughout this tenure, Dr. Hu’s research focused on cancer photodynamic therapy, with a particular emphasis on developing novel strategies to enhance its effectiveness. This involved the design and development of smart nanomedicines based on various conjugates and drug combinations to address challenges such as tumor hypoxia and intracellular glutathione levels. Dr. Hu has contributed significantly to the field, co-authoring over 40 SCI papers and applying for over 30 invention patents. Additionally, Dr. Hu’s research has been recognized and published in reputable journals, highlighting the originality and significance of the work in cancer therapy and drug delivery systems.

Research Interest:

Dr. Hang Hu’s research interests primarily revolve around cancer photodynamic therapy (PDT) and drug delivery systems. Specifically, Dr. Hu is interested in developing innovative strategies to enhance the efficacy of PDT by addressing key challenges such as tumor hypoxia, high intracellular glutathione levels, and insufficient photosensitizer uptake. This involves the design and synthesis of smart nanomedicines using various materials and drug combinations to potentiate PDT effects. Additionally, Dr. Hu is interested in exploring the mechanisms underlying PDT and the development of novel photosensitizers with improved selectivity and efficacy against cancer cells. The ultimate goal of Dr. Hu’s research is to contribute to the advancement of cancer therapy by developing effective and targeted treatment strategies that minimize side effects and improve patient outcomes.

Publication Top Noted:

Title: Application of mesoporous calcium silicate nanoparticles as a potential SD carrier to improve the solubility of curcumin

  • Authors: Deng, J., Wang, J., Hu, H., Zhou, H., Xu, D.
  • Journal: Journal of Dispersion Science and Technology
  • Year: 2023
  • Volume: 44
  • Citation Count: 4

Title: Conjugates of lactobionic acid and IR820: New photosensitizers for efficient photodynamic therapy of hepatoma cells

  • Authors: Yuan, X., Tao, Y., Xiao, W., Xu, D., Xu, Q.
  • Journal: Drug Development Research
  • Year: 2022
  • Volume: 83
  • Citation Count: 3

Title: pH-Sensitive nanoparticles co-loaded with dimethylcurcumin and regorafenib for targeted combinational therapy of hepatocellular carcinoma

  • Authors: Hu, H., Xu, D.
  • Journal: European Polymer Journal
  • Year: 2022
  • Citation Count: 1

Title: A comparative study of the in vitro antitumor effect of mannose-doxorubicin conjugates with different linkers

  • Authors: Cui, X., Du, K., Yuan, X., Xu, D., Hu, H.
  • Journal: Drug Development Research
  • Year: 2022
  • Volume: 83
  • Citation Count: 4

Title: Mesoporous polydopamine-based multifunctional nanoparticles for enhanced cancer phototherapy

  • Authors: Hu, H., Liu, X., Hong, J., Li, Z., Xu, D.
  • Journal: Journal of Colloid and Interface Science
  • Year: 2022
  • Volume: 612
  • Citation Count: 29